Urethral Pain Syndrome: Treatment with Oxygen and Hyaluronic Acid
DOI:
https://doi.org/10.3889/oamjms.2023.10756Keywords:
urethral, pain, syndrome, treatment, oxygen therapy, hyaluronic acidAbstract
AIM: The aim of our clinical study has been to evaluate the efficacy of the association between high concentration oxygen and hyaluronic acid (HA) for the treatment of urethral pain syndrome (UPS).
MATERIALS AND METHODS: Twenty women (45–65 years old) with suspected UPS diagnosis appealing to our Second Opinion Medical Consultation Network signed an informed consent form and were treated with oxygen/HA therapy treatment, 7 times a week, for a total of 5 weeks at the outpatient clinic (Clinic Ester Veronesi, Modena, Italy).The physicians of the Second Opinion Network followed up weekly from remote (WhatsApp, Skype) each treated patient as to state the effectiveness, tolerability, and side effects of the treatment.
RESULTS: We observed significant reductions in number of urgency urinary incontinence (−25.37 vs. −12.01 mean value), nocturia episodes (−24.01 vs. −11.23 mean value), volume voided in each micturition (−127.79 vs. −98.20 mean value), and micturitions per 24 h (−44.01 vs. −20.12 mean value). Analyses of the pre- and post-treatment scores showed a statistically significant improvement in Vaginal assessment scale, pain urgency frequency, and patient perception of bladder condition scale scores (p < 0.0305, p < 0.0001, and p < 0.0001, respectively). No side effects associated with the treatment were reported by the patients.
CONCLUSIONS: We can highlight that Caressflow® is effective and very well tolerated in UPS syndrome: The oxygen flow mixed with HA gives immediately a sense of freshness and urethro-bladder relaxation that lasts several hours. Further studies including larger sample sizes, placebo, and or challenge with other local and systemic treatments and different administration schedules versus longer follow-up are recommended.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Abrams P, Blaivas JG, Stanton SL, Andersen JT. The standardisation of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology. Scand J Urol Nephrol Suppl. 1988;114:5-19. PMid:3201169 DOI: https://doi.org/10.1002/nau.1930070502
Gallagher DJ, Montgomerie JZ, North JD. Acute infections of the urinary tract and the urethral syndrome in general practice. Br Med J. 1965;1(5435):622-6. https://doi.org/10.1136/bmj.1.5435.622 PMid:14245177 DOI: https://doi.org/10.1136/bmj.1.5435.622
Youngblood VH, Tomlin EM, Davis JB. Senile urethritis in women. J Urol. 1957;78(2):150-2. https://doi.org/10.1016/ s0022-5347(17)66413-9 PMid:13450004 DOI: https://doi.org/10.1016/S0022-5347(17)66413-9
Piontek K, Ketels G, Albrecht R, Schnurr U, Dybowski C, Brünahl CA, et al. Somatic and psychosocial determinants of symptom severity and quality of life in male and female patients with chronic pelvic pain syndrome. J Psychosom Res.
;120:1-7. https://doi.org/10.1016/j.jpsychores.2019.02.010 PMid:30929698 DOI: https://doi.org/10.1016/j.jpsychores.2019.02.010
Passavanti MB, Pota V, Sansone P, Aurilio C, De Nardis L, Pace MC. Chronic pelvic pain: Assessment, evaluation, and objectivation. Pain Res Treat. 2017;2017:9472925. https://doi.org/10.1155/2017/9472925 PMid:29359045 DOI: https://doi.org/10.1155/2017/9472925
Phillip H, Okewole I, Chilaka V. Enigma of urethral pain syndrome: Why are there so many ascribed etiologies and therapeutic approaches? Int J Urol. 2014;21(6):544-8. https:/doi.org/10.1111/iju.12396 PMid:24447292 DOI: https://doi.org/10.1111/iju.12396
Gürel H, Gürel SA, Atilla MK. Urethral syndrome and associated risk factors related to obstetrics and gynecology. Eur J Obstet Gynecol Reprod Biol. 1999;83(1):5-7. https://doi.org/10.1016/s0301-2115(98)00153-5 PMid:10221602 DOI: https://doi.org/10.1016/S0301-2115(98)00153-5
Tait J, Peddie BA, Bailey RR, Arnold EP, Russell GL, Bishop VA, et al. Urethral syndrome (abacterial cystitis)-- search for a pathogen. Br J Urol. 1985;57(5):552-6. https://doi.org/10.1111/j.1464-410x.1985.tb05865.x PMid:2998533 DOI: https://doi.org/10.1111/j.1464-410X.1985.tb05865.x
Bogart LM, Suttorp MJ, Elliott MN, Clemens JQ, Berry SH. Validation of a quality-of-life scale for women with bladder pain syndrome/interstitial cystitis. Qual Life Res. 2012;21(9):1665-70. https://doi.org/10.1007/s11136-011-0085-3 PMid:22146841 DOI: https://doi.org/10.1007/s11136-011-0085-3
Zufall R. Ineffectiveness of treatment of urethral syndrome in women. Urology. 1978;12(3):337-9. https:/doi.org/10.1016/0090-4295(78)90401-6 PMid:568343 DOI: https://doi.org/10.1016/0090-4295(78)90401-6
Dreger NM, Degener S, Roth S, Brandt AS, Lazica DA. Urethral pain syndrome: Fact or fiction--an update. Der Urologe Ausg A. 2015;54(9):1248-55. https://doi.org/10.1007/ s00120-015-3926-9 PMid:26337167
Gittes RF, Nakamura RM. Female urethral syndrome. A female prostatitis? West J Med. 1996;164(5):435-8. PMid:8686301
Aziz Q, Giamberardino MA, Barke A, Korwisi B, Baranowski AP, Wesselmann U, et al. The IASP classification of chronic pain for ICD-11: Chronic secondary visceral pain. Pain. 2019;160(1):69-76. https://doi.org/10.1097/j.pain.0000000000001362 PMid:30586073 DOI: https://doi.org/10.1097/j.pain.0000000000001362
Bernstein AM, Philips HC, Linden W, Fenster H. A psychophysiological evaluation of female urethral syndrome: Evidence for a muscular abnormality. J Behav Med. 1992;15(3):299-312. https://doi.org/10.1007/BF00845358 PMid:1625341 DOI: https://doi.org/10.1007/BF00845358
Raz S, Smith RB. External sphincter spasticity syndrome in female patients. J Urol. 1976;115(4):443-6. https://doi.org/10.1016/s0022-5347(17)59235-6 PMid:944276 DOI: https://doi.org/10.1016/S0022-5347(17)59235-6
Parsons CL. The role of a leaky epithelium and potassium in the generation of bladder symptoms in interstitial cystitis/overactive bladder, urethral syndrome, prostatitis and gynaecological chronic pelvic pain. BJU Int. 2011;107(3):370-5. https://doi.org/10.1111/j.1464-410X.2010.09843.x PMid:21176078 DOI: https://doi.org/10.1111/j.1464-410X.2010.09843.x
Stamm WE, Wagner KF, Amsel R, Alexander ER, Turck M, Counts GW, et al. Causes of the acute urethral syndrome in women. N Engl J Med. 1980;303(8):409-15. https://doi.org/10.1056/NEJM198008213030801 PMid:6993946 DOI: https://doi.org/10.1056/NEJM198008213030801
Rothberg MB, Wong JB. All dysuria is local. A cost-effectiveness model for designing site-specific management algorithms. J Gen Intern Med. 2004;19(5 Pt 1):433-43. https://doi.org/10.1111/j.1525-1497.2004.10440.x PMid:15109341 DOI: https://doi.org/10.1111/j.1525-1497.2004.10440.x
Dreger NM, Degener S, Roth S, Brandt AS, Lazica DA. Das urethralsyndrom: Fakt oder fiktion-ein update. Der Urologe. 2015;54(9):1248-55. DOI: https://doi.org/10.1007/s00120-015-3926-9
Kaur H, Arunkalaivanan AS. Urethral pain syndrome and its management. Obstet Gynecol Surv. 2007;62:348-51; quiz 53-4. https://doi.org/10.1097/01.ogx.0000261645.12099.2a PMid:17425813 DOI: https://doi.org/10.1097/01.ogx.0000261645.12099.2a
Yoon SM, Jung JK, Lee SB, Lee T. Treatment of female urethral syndrome refractory to antibiotics. Yonsei Med J. 2002;43(5):644-51. https://doi.org/10.3349/ymj.2002.43.5.644 PMid:12402379 DOI: https://doi.org/10.3349/ymj.2002.43.5.644
Karam MR, Habibi M, Bouzari S. Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli. Mol Immunol. 2019;108:56-67. https://doi.org/10.1016/j.molimm.2019.02.007 PMid:30784763 DOI: https://doi.org/10.1016/j.molimm.2019.02.007
Kellar RS, Audet RG, Roe DF, Rheins LA, Draelos ZD. Topically delivered dissolved oxygen reduces inflammation and positively influences structural proteins in healthy intact human skin. J Cosmet Dermatol. 2013;12(2):86-95. https://doi.org/10.1111/ jocd.12039 PMid:23725301 DOI: https://doi.org/10.1111/jocd.12039
Dieleman FJ, Phan TT, van den Hoogen FJ, Kaanders J, Merkx MA. The efficacy of hyperbaric oxygen therapy related to the clinical stage of osteoradionecrosis of the mandible. Int J Oral Maxillofac Surg. 2017;46(4):428-33. https://doi.org/10.1016/j.ijom.2016.12.004 PMid:28043745 DOI: https://doi.org/10.1016/j.ijom.2016.12.004
Chen J, Geng L, Song X, Li H, Giordan N, Liao Q. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: A multicenter, randomized, controlled, open-label, parallel-group, clinical trial. J Sex Med. 2013;10(6):1575-84. https://doi.org/10.1111/jsm.12125 PMid:23574713 DOI: https://doi.org/10.1111/jsm.12125
Streltsova O, Kuyarov A, Molvi M, Zubova S, Lazukin V, Tararova E, et al. New approaches in the study of the pathogenesis of urethral pain syndrome. Diagnostics (Basel, Switzerland). 2020;10(11):860. https://doi.org/10.3390/diagnostics10110860 PMid:33105749 DOI: https://doi.org/10.3390/diagnostics10110860
Persu C, Cauni V, Gutue S, Blaj I, Jinga V, Geavlete P. From interstitial cystitis to chronic pelvic pain. J Med Life 2010;3:167-74. PMid:20968203
Stecco C. Functional Atlas of the Human Fascial System. 1st ed. London, UK: Elsevier Health Sciences; 2014. p. 384. DOI: https://doi.org/10.1016/B978-0-7020-4430-4.00001-4
Langevin HM. Connective tissue: A body-wide signaling network? Med Hypotheses. 2006;66(6):1074-7. https://doi.org/10.1016/j.mehy.2005.12.032 PMid:16483726 DOI: https://doi.org/10.1016/j.mehy.2005.12.032
Shoskes DA, Nickel JC, Kattan MW. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: A prospective study using UPOINT. Urology. 2010;75(6):1249-53. https://doi.org/10.1016/j.urology.2010.01.021 PMid:20363491 DOI: https://doi.org/10.1016/j.urology.2010.01.021
Bamber J, Cosgrove D, Dietrich CF, Fromageau J, Bojunga J, Calliada F, et al. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology. Ultraschall Med. 2013;34(02):169-84. https://doi.org/10.1055/s-0033-1335205 PMid:23558397 DOI: https://doi.org/10.1055/s-0033-1335205
Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, et al. Optical coherence tomography. Science (New York, NY). 1991;254(5035):1178-81. https://doi.org/10.1126/science.1957169 PMid:1957169 DOI: https://doi.org/10.1126/science.1957169
Drexler W, Liu M, Kumar A, Kamali T, Unterhuber A, Leitgeb RA. Optical coherence tomography today: Speed, contrast, and multimodality. J Biomed Optics. 2014;19(7):071412. https://doi.org/10.1117/1.JBO.19.7.071412 PMid:25079820 DOI: https://doi.org/10.1117/1.JBO.19.7.071412
Gelikonov VM, Gelikonov GV. New approach to cross-polarized optical coherence tomography based on orthogonal arbitrarily polarized modes. Laser Phys Lett. 2006;3(9):445-51. https://doi.org/10.1002/lapl.200610030 DOI: https://doi.org/10.1002/lapl.200610030
Kiseleva EB, Moiseev AA, Kuyarov A, Molvi MA, Gelikonov GV, Maslennikova AV, et al. In vivo assessment of structural changes of the urethra in lower urinary tract disease using cross- polarization optical coherence tomography. J Innov Optic Health Sci. 2020;13:2050024. https://doi.org/10.1142/S1793545820500248 DOI: https://doi.org/10.1142/S1793545820500248
Wunsch A, Palmieri B. The rôle of second opinion in oncology: An update. Eur J Oncol. 2014;18(3):117-20.
Palmieri B, Iannitti T, Capone S, Fistetto G, Arisi E. Second opinion clinic: Is the Web Babel Syndrome treatable? Clin Ter. 2011;162(6):575-83. PMid:22262332
Palmieri BL, Vadalà M. The “second opinion medical network”. Int J Pathol and Clin Res. 2017;3:1-7. DOI: https://doi.org/10.23937/2469-5807/1510056
Di Cerbo A, Palmieri B. The economic impact of second opinion in pathology. Saudi Med J. 2012;33(10):1051-2. PMid:23047210
Lin CC, Sawada JA, Wu L, Haastrup T, Kuznicki SM. Anion- controlled pore size of titanium silicate molecular sieves. J Am Chem Soc. 2009;131(2):609-14. https://doi.org/10.1021/ja806114z PMid:19113845 DOI: https://doi.org/10.1021/ja806114z
Breck DW. Zeolite molecular sieves: Structure, chemistry, and use D. W. Breck (Union Carbide Corporation, Tarrytown, New York) John Wiley and Sons, New York, London, Sydney, and Toronto. 1974. 771 pp. $11.95. J Chromatograp Sci. 1975;13(4):18A. DOI: https://doi.org/10.1093/chromsci/13.4.18A-c
Coyne KS, Matza LS, Kopp Z, Abrams P. The validation of
the patient perception of bladder condition (PPBC): A single- item global measure for patients with overactive bladder. Eur Urol. 2006;49(6):1079-86. https://doi.org/10.1016/j.eururo.2006.01.007 PMid:16460875 DOI: https://doi.org/10.1016/j.eururo.2006.01.007
Minaglia S, Ozel B, Nguyen JN, Mishell DR Jr. Validation of Spanish version of Pelvic Pain and Urgency/Frequency (PUF) patient symptom scale. Urology. 2005;65(4):664-9. https://doi.org/10.1016/j.urology.2004.10.078 PMid:15833505 DOI: https://doi.org/10.1016/j.urology.2004.10.078
Condemi L, Di Giuseppe J, Delli Carpini G, Garoia F, Frega A, Ciavattini A. Vaginal natural oxygenation device (VNOD) for concomitant administration of hyaluronic acid and topical hyperbaric oxygen to treat vulvo-vaginal atrophy: a pilot study. Eur Rev Med Pharmacol Sci. 2018;22:8480-6. https://doi.org/10.26355/eurrev_201812_16548. PMid: 30556890
Hunt TK, Pai MP. The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg Gynecol Obstet.1972;135:561-7.
Tandara AA, Mustoe TA. Oxygen in wound healing--more than a nutrient. World J Surg. 2004;28:294-300. https://doi.org/10.1007/s00268-003-7400-2. PMid: 14961188 DOI: https://doi.org/10.1007/s00268-003-7400-2
Camporesi EM, Bosco G. Mechanisms of action of hyperbaric oxygen therapy. Undersea Hyperb Med. 2014;41:247-52.
Tezel A, Fredrickson GH. The science of hyaluronic acid dermal fillers. J Cosmet Laser Ther. 2008;10:35-42. https://doi.org/10.1080/14764170701774901. PMid: 18330796 DOI: https://doi.org/10.1080/14764170701774901
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Maria Vadalà, Ester Veronesi, Flavio Garoia (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
